Guardant Health, Inc.
Guardant Health, Inc. (GH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
gh · stock forecast · 30 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 30 Wall Street analysts in the past 3 months
Buy
30 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$175
Consensus
$143
+12.8% upside
Low
$115
Median: $135 · Last Close: $126.70
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$142.93
12.8% upside
High Target
$175
38.1%
Low Target
$115
-9.2%
Current Price
$126.70
as of today
Based on analyst price targets, the GH stock price prediction for the next 12 months ranges from $115 to $175. The consensus GH price forecast of $142.93 implies 12.8% upside from the current price of $126.70.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $133.03 | ↑ 5.00% |
1-day model range: $131.96–$134.11. Peak: $134.11 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $165 | +29.9% |
| 2028 | $197 | +55.2% |
| 2029 | $222 | +74.8% |
| 2030 | $240 | +89.2% |
| 2031 | — | +99.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GH · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-05 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-06-02 | Evercore ISI Group | Upgrade ↑ | In Line→Outperform |
| 2026-05-27 | BTIG | Maintains | Buy→Buy |
| 2026-05-26 | BTIG | Maintains | Buy→Buy |
| 2026-05-08 | Evercore ISI Group | Maintains | In Line→In Line |
| 2026-05-08 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-08 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-14 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-06 | Evercore ISI Group | Maintains | In Line→In Line |
| 2026-02-24 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Guardant Health, Inc. (GH) stock. Of the recent 167 rating actions, 8 were upgrades and 4 were downgrades. 30 analysts currently cover GH.
Analyst Recommendation Trends
GH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 9 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.3B
↓ 39.4% YoY
Revenue Next Year
$1.7B
↑ 28.9% YoY
EPS This Year
$-2.93
EPS Next Year
$-2.02
↓ 31.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast GH EPS of $-2.93 for the current fiscal year, based on estimates from 11 analysts. The GH revenue forecast is $1.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GH stock forecast is supported by two independent data sources: analyst consensus ratings from 30 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GH price target is $142.93 (+12.8% upside), with an analyst consensus of Buy.
The GH short-term stock prediction for tomorrow is $133.03 (+5.00%). The GH stock price prediction for 2027 estimates an average of $165. The GH stock prediction for 2030 projects a range of $219–$261.
Guardant Health, Inc. trades on NASDAQ under the ticker GH. The GH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 97% of covering analysts.
Frequently asked questions
GH forecast · 8 questionsAccording to 30 Wall Street analysts, the average 12-month GH price target is $142.93, with a high forecast of $175.00 and a low of $115.00. The median price target is shown in the chart above when available. This implies +12.8% potential upside from the current price of $126.70.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.